{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:25:07Z","timestamp":1787066707711,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13181-022-00900-8","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T12:03:07Z","timestamp":1654516987000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Front-Loaded Versus Low-Intermittent Phenobarbital Dosing for Benzodiazepine-Resistant Severe Alcohol Withdrawal Syndrome"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-3944","authenticated-orcid":false,"given":"Poorvi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati L.","family":"Stegner-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/S0140-6736(97)04572-8","volume":"349","author":"W Hall","year":"1997","unstructured":"Hall W, Zador D. The alcohol withdrawal syndrome. Lancet. 1997;349:1897\u2013900.","journal-title":"Lancet"},{"key":"900_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1399-6576.2005.00839.x","volume":"49","author":"A Uusaro","year":"2005","unstructured":"Uusaro A, Parviainen I, Tenhunen JJ, Ruokonen E. The proportion of intensive care unit admissions related to alcohol use: a prospective cohort study. Acta Anaesthesiol Scand. 2005;49:1236\u201340.","journal-title":"Acta Anaesthesiol Scand"},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1111\/acer.12529","volume":"38","author":"CM Goodson","year":"2014","unstructured":"Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res. 2014;38:2664\u201377.","journal-title":"Alcohol Clin Exp Res"},{"key":"900_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","volume":"373","author":"MA Schuckit","year":"2009","unstructured":"Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492\u2013501.","journal-title":"Lancet"},{"key":"900_CR5","doi-asserted-by":"publisher","first-page":"S494","DOI":"10.1097\/CCM.0b013e3181ec5412","volume":"38","author":"M Sarff","year":"2010","unstructured":"Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010;38:S494-501.","journal-title":"Crit Care Med"},{"key":"900_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03161171","volume":"2","author":"JB Hack","year":"2006","unstructured":"Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006;2:55\u201360.","journal-title":"J Med Toxicol"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/phar.1770","volume":"36","author":"D Dixit","year":"2016","unstructured":"Dixit D, Endicott J, Burry L, Ramos L, Yeung SYA, Devabhakthuni S, et al. Management of acute alcohol withdrawal syndrome in critically Ill patients. Pharmacotherapy. 2016;36:797\u2013822.","journal-title":"Pharmacotherapy"},{"key":"900_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcrc.2014.10.008","volume":"30","author":"A Wong","year":"2015","unstructured":"Wong A, Benedict NJ, Kane-Gill SL. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. J Crit Care. 2015;30:405\u20139.","journal-title":"J Crit Care"},{"key":"900_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jcrc.2015.11.022","volume":"32","author":"Y Mo","year":"2016","unstructured":"Mo Y, Thomas MC, Karras GE Jr. Barbiturates for the treatment of alcohol withdrawal syndrome: a systematic review of clinical trials. J Crit Care. 2016;32:101\u20137.","journal-title":"J Crit Care"},{"key":"900_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psym.2016.02.011","volume":"57","author":"K Martin","year":"2016","unstructured":"Martin K, Katz A. The role of barbiturates for alcohol withdrawal syndrome. Psychosomatics. 2016;57:341\u20137.","journal-title":"Psychosomatics"},{"key":"900_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0196-0644(87)80520-6","volume":"16","author":"GP Young","year":"1987","unstructured":"Young GP, Rores C, Murphy C, Dailey RH. Intravenous phenobarbital for alcohol withdrawal and convulsions. Ann Emerg Med. 1987;16:847\u201350.","journal-title":"Ann Emerg Med"},{"key":"900_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/01.CCM.0000256841.28351.80","volume":"35","author":"JA Gold","year":"2007","unstructured":"Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35:724\u201330.","journal-title":"Crit Care Med"},{"key":"900_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","volume":"44","author":"J Rosenson","year":"2013","unstructured":"Rosenson J, Clements C, Simon B, Vieaux J, Graffman S, Vahidnia F, et al. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013;44:592\u20138.","journal-title":"J Emerg Med"},{"key":"900_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/TA.0000000000000352","volume":"77","author":"JJ Duby","year":"2014","unstructured":"Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014;77:938\u201343.","journal-title":"J Trauma Acute Care Surg"},{"key":"900_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4037\/ajcc2018745","volume":"27","author":"WP Tidwell","year":"2018","unstructured":"Tidwell WP, Thomas TL, Pouliot JD, Canonico AE, Webber AJ. Treatment of alcohol withdrawal syndrome: phenobarbital vs CIWA-Ar protocol. Am J Crit Care. 2018;27:454\u201360.","journal-title":"Am J Crit Care"},{"key":"900_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1592\/phco.29.7.875","volume":"29","author":"CE Hayner","year":"2009","unstructured":"Hayner CE, Wuestefeld NL, Bolton PJ. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy. 2009;29:875\u20138.","journal-title":"Pharmacotherapy"},{"key":"900_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ajem.2009.10.010","volume":"29","author":"GW Hendey","year":"2011","unstructured":"Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P. A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med. 2011;29:382\u20135.","journal-title":"Am J Emerg Med"},{"key":"900_CR18","first-page":"A4169","volume":"57","author":"IH Michaelsen","year":"2010","unstructured":"Michaelsen IH, Anderson JE, Fink-Jensen A, Allerup P, Ulrichsen J. Phenobarbital versus diazepam for delirium tremens-a retrospective study. Dan Med Bull. 2010;57:A4169.","journal-title":"Dan Med Bull"},{"key":"900_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajem.2019.01.002","volume":"37","author":"AC Nelson","year":"2019","unstructured":"Nelson AC, Kehoe J, Sankoff J, Mintzer D, Taub J, Kaucher KA. Benzodiazepines vs barbiturates for alcohol withdrawal: analysis of 3 different treatment protocols. Am J Emerg Med. 2019;37:733\u20136.","journal-title":"Am J Emerg Med"},{"key":"900_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0885066618783947","volume":"35","author":"M Oks","year":"2018","unstructured":"Oks M, Cleven KL, Healy L, Wei M, Narasimhan M, Mayo PH, et al. The safety and utility of phenobarbital use for the treatment of severe alcohol withdrawal syndrome in the medical intensive care unit. J Intensive Care Med. 2018;35:844\u201350.","journal-title":"J Intensive Care Med"},{"key":"900_CR21","first-page":"31","volume":"4","author":"LZ Gashlin","year":"2015","unstructured":"Gashlin LZ, Groth CM, Wiegand TJ, Ashley ED. Comparison of alcohol withdrawal outcomes in patients treated with benzodiazepines alone versus adjunctive phenobarbital: a retrospective cohort study. Asia Pac J Med Toxicol. 2015;4:31\u20136.","journal-title":"Asia Pac J Med Toxicol"},{"key":"900_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00007611-199101000-00006","volume":"84","author":"TJ Ives","year":"1991","unstructured":"Ives TJ, Mooney AJ 3rd, Gwyther RE. Pharmacokinetic dosing of phenobarbital in the treatment of alcohol withdrawal syndrome. South Med J. 1991;84:18\u201321.","journal-title":"South Med J"},{"key":"900_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.psym.2019.02.002","volume":"60","author":"M Nisavic","year":"2019","unstructured":"Nisavic M, Nejad SH, Isenberg BM, Bajwa EK, Currier P, Wallace PM, et al. Use of phenobarbital in alcohol withdrawal management - a retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients. Psychosomatics. 2019;60:458\u201367.","journal-title":"Psychosomatics"},{"key":"900_CR24","doi-asserted-by":"crossref","first-page":"232470961774216","DOI":"10.1177\/2324709617742166","volume":"5","author":"J Fujimoto","year":"2017","unstructured":"Fujimoto J, Lou JJ, Pessegueiro AM. Use of phenobarbital in delirium tremens. J Investig Med High Impact Case Rep. 2017;5:2324709617742166.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"900_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0018578717720310","volume":"52","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Rowe JM, Wong A, Wiley TL, Lee KC, Kane-Gill SL. Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review. Hosp Pharm. 2017;52:607\u201316.","journal-title":"Hosp Pharm"},{"key":"900_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13181-018-0678-0","volume":"14","author":"J Larsen","year":"2018","unstructured":"Larsen J, Mycyk MB, Thompson TM. Reviewing the record: medical record reviews for medical toxicology research. J Med Toxicol. 2018;14:179\u201381.","journal-title":"J Med Toxicol"},{"key":"900_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13181-018-0662-8","volume":"14","author":"P Shah","year":"2018","unstructured":"Shah P, McDowell M, Ebisu R, Hanif T, Toerne T. Adjunctive use of ketamine for benzodiazepine-resistant severe alcohol withdrawal: a retrospective evaluation. J Med Toxicol. 2018;14:229\u201336.","journal-title":"J Med Toxicol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-022-00900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-022-00900-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-022-00900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:26:58Z","timestamp":1655213218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-022-00900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1007\/s13181-022-00900-8","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}